Skip to content

Clinical trials

Phase 2 Glioblastoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: China Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20151
20161
20171
20204
20216
20222
20234
20244
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11
Recruiting10
Not yet recruiting4
Completed4
Active, not recruiting1
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine5
Huashan Hospital3
Beijing Sanbo Brain Hospital2
Henan Provincial People's Hospital2
Peking Union Medical College Hospital2
Tianjin Medical University General Hospital2
BioNTech SE1
Biotech Pharmaceutical Co., Ltd.1
CANbridge Life Sciences Ltd.1
Fifth Affiliated Hospital, Sun Yat-Sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma32
Brain Neoplasms3
Glioma3
Hypoxia1
Meningeal Carcinomatosis1
Neoplasms1
Recurrence1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.